Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Adamidi, N. Soulitzis, E. Neofytou, A. Georgiou, K. Benidis, A. Papadopoulos, N. M. Siafakas, S. E. Schiza (Nikosia, Cyprus; Heraklion, Greece). Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions?. Eur Respir J 2014; 44: Suppl. 58, 2776

Member's Comments

No comment yet.

Related content which might interest you: Association of biochemical determinants and fibrinous formation in malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Role of fibulin-3 in the diagnosis of malignant mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Comparison of multiple serum and pleural fluid biomarkers for the diagnosis of Malignant Pleural Mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Predictive value of pro-inflammatory cytokine and pro-angiogenic factor in differentiating malignant from benign exudative effusion Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Analysis of amylase rich pleural effusions Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Value of thoracoscopic pleural brush in the diagnosis of exudative pleural effusion Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 1,25-dihydroxyvitamin D in malignant and non-malignant pleural effusions Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Yield of pleural cytology and macroscopic pleural invasion in metastatic pleural effusion Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Biological markers of successful pleurodesis for malignant pleural effusion Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016 Ultrasound guided needle pleural biopsy in patients with undiagnosed pleural effusion Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 High fluorescence cells in pleural fluid. Association with pleural malignancy Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Serum procalcitonin as a potential biomarker of surgery in parapneumonic pleural effusions Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Pleural and mediastinal diseases Source: HERMES Summer School 2014 - Educational material Year: 2014 Pleural and mediastinal diseases Source: ERS Skills Course 2016 Year: 2016 Pleural and mediastinal diseases Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Pleural and mediastinal diseases Source: ERS Course 2015 Year: 2015